← Eichor
Condition: Oligometastases Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Oligometastases

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

SBRT Alone or Followed by Niraparib for Oligometastases or Oligoprogression in Ovarian Cancer Following PARPi Therapy
Phase 2 · 7 location(s) · Institute of Cancer Research, United Kingdom · NCT05990192En Bloc Resection Versus Separation Surgery Combined With Radiotherapy for the Treatment of Spinal Oligometastatic Tumor
Phase N/A · 1 location(s) · Shanghai Changzheng Hospital · NCT06120426Markerless Image Guidance Using Intrafraction Kilovoltage X-ray Imaging
NA · 1 location(s) · University of Sydney · NCT04086082A Neurocognitive Study in Patients With Brain Oligometastases Receiving Hypofractionated SRT
Phase N/A · 2 location(s) · Chang Gung Memorial Hospital · NCT04805255SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With Oligometastases
Phase 2 · 1 location(s) · First Affiliated Hospital of Zhejiang University · NCT06850103A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Sync
Phase 3 · 5 location(s) · David Palma · NCT05717166Local Consolidative Radiation Therapy Plus TKI Versus TKI Alone in Driver Mutated OM-NSCLC
Phase 2 · 1 location(s) · Tata Memorial Hospital · NCT05277844Metastasis-directed Therapy for Oligometastases of Breast Cancer
Phase 3 · 1 location(s) · Tokyo Medical and Dental University · NCT06135714Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Ca
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT03161522The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Phase N/A · 18 location(s) · UMC Utrecht · NCT04075305Advanced Radiotherapy (ART) in Gynecological Cancer Patients (GYN-ART)
Phase N/A · 1 location(s) · IRCCS San Raffaele · NCT06306170Elimination of PTV Margins Based on Online Adaptive Stereotactic Radiotherapy for Early-stage Non-small Cell Lung Cancer
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT06542159Efficacy and Safety of SBRT Combined With Becotatug Vedotin (MRG003) in EGFR-Positive Metastatic Tumor Patients With Oli
Phase 3 · 2 location(s) · Ming-Yuan Chen · NCT07481799Adaptive Fractionation in Online Adaptive Stereotactic Radiotherapy for Abdominopelvic Lymph Node Oligometastases
NA · 1 location(s) · Joost J. M. E. Nuyttens · NCT07415356Treatment With Darolutamide +/- Radiation Therapy for Patients With a Castration Resistant Cancer and Metastases Detecte
Phase 3 · 4 location(s) · UNICANCER · NCT06276465Stereotactic Ablative Radiotherapy (XRT) and Immunotherapy for Oligometastatic Extracranial Melanoma
Phase 2 · 5 location(s) · Melanoma Institute Australia · NCT06767306Single vs. Multiple Fraction Trial of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastases/
NA · 14 location(s) · Robert Olson · NCT05784428Phase II Study of Radiotherapy Followed by Durvalumab and Ceralasertib in Stage III NSCLC Patients With Thoracic Relapse
Phase 2 · 9 location(s) · Mario Negri Institute for Pharmacological Research · NCT06680050BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + SBRT for BCLC-C HCC With PVTT and/or Oligometastases
Phase 2 · 1 location(s) · Shandong Cancer Hospital and Institute · NCT07062055Delayed Systemic Therapy Following Destructive Local Treatment of Pulmonary Oligometastases After No Evidence of Disease
Phase 2 · 1 location(s) · Shandong Cancer Hospital and Institute · NCT067783825500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT)
NA · 4 location(s) · British Columbia Cancer Agency · NCT04610372
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.